About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) is pleased to submit comments on the proposed rule published by the HHS Office of the Inspector General (OIG) concerning safe harbor protections under the Federal Anti-Kickback Statute (AKS) and exceptions to the Civil Monetary Penalty (CMP) law regarding beneficiary inducements for certain coordinated care, value-based, and patient engagement arrangements.
Download the full letter below.
PhRMA Comment on OIG Regulatory Sprint Proposed Rule image
Comment
Cost and Value
PhRMA Comment on OIG Regulatory Sprint Proposed Rule
PhRMA Comment on OIG Regulatory Sprint Proposed Rule image